Taking a Closer Look At Amphastar Pharmaceuticals Inc (AMPH) Following Its Recent Trade

Amphastar Pharmaceuticals Inc’s filing revealed that its Director Petersen Floyd F. unloaded Company’s shares for reported $11734.0 on Jul 02 ’25. In the deal valued at $23.47 per share,500 shares were sold. As a result of this transaction, Petersen Floyd F. now holds 77,531 shares worth roughly $1.75 million.

Then, Petersen Floyd F. bought 500 shares, generating $11,715 in total proceeds.

Before that, Petersen Floyd F. sold 500 shares. Amphastar Pharmaceuticals Inc shares valued at $12,835 were divested by the Director at a price of $25.67 per share. As a result of the transaction, Petersen Floyd F. now holds 72,909 shares, worth roughly $1.65 million.

JP Morgan downgraded its Amphastar Pharmaceuticals Inc [AMPH] rating to a Neutral from a an Overweight in a research note published recently. A number of analysts have revised their coverage, including Piper Sandler’s analysts, who decreased its forecast for the stock in early February from “an Overweight” to “a Neutral”. Wells Fargo began covering AMPH with “an Equal weight” recommendation on November 22, 2024. JP Morgan started covering the stock on March 05, 2024. It rated AMPH as “an Overweight”.

Price Performance Review of AMPH

On Tuesday, Amphastar Pharmaceuticals Inc [NASDAQ:AMPH] saw its stock fall -1.14% to $22.6. Over the last five days, the stock has lost -1.57%. Amphastar Pharmaceuticals Inc shares have fallen nearly -41.39% since the year began. Nevertheless, the stocks have fallen -39.13% over the past one year. While a 52-week high of $53.96 was reached on 01/15/25, a 52-week low of $22.64 was recorded on 07/08/25.

Levels Of Support And Resistance For AMPH Stock

The 24-hour chart illustrates a support level at 22.23, which if violated will result in even more drops to 21.85. On the upside, there is a resistance level at 23.18. A further resistance level may holdings at 23.75.

How much short interest is there in Amphastar Pharmaceuticals Inc?

A steep rise in short interest was recorded in Amphastar Pharmaceuticals Inc stocks on 2025-06-13, growing by 74620.0 shares to a total of 4.08 million shares. Yahoo Finance data shows the prior-month short interest on 2025-05-15 was 4.01 million shares. There was a rise of 1.83%, which implies that there is a positive sentiment for the stock.

The most recent change occurred on November 17, 2023 when BofA Securities began covering the stock and recommended ‘”a Neutral”‘ rating along with a $63 price target.

Most Popular

Knox Daily
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.